1Hakkinen T, Luoma JS, Hiltunen MO, et al. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions [ J ]. Arterioscler Thromb Vasc Biol, 1999, 19 (12) : 2909-2917.
2Stanfforini DM, Tjoelker LW, McCormick SP, et al. Molecular basis of the interaction between plasma platelet-activating factor and tow density lipoprotein [ J ]. J Biol Chem, 1999, 274( 11 ) :7018-7024.
3Yang EH, McConnell JP, Lennon R J, et al. Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans [ J ]. Arterioscler Thromb Vasc Biol, 2006, 26 ( 1 ) : 106-110.
4Mannheim D, Herrmann J, Versari D, et al. Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotie plaques [ J ]. Stroke, 2008,39 ( 5 ) : 1448-1455.
5Iribarren C, Gross MD, Darbinian JA, et al. Association of lipoproteinassociated phospholipase A2 mass and activity with calcified coronary plaque in young adults : the CARDIA study [ J ]. Arterioscler Thromb Vasc Biol, 2005, 25(1):216-221.
6Schaefer E J, McNamara JR, Asztalos BF, et al. Effects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart disease versus control subjects [ J ]. Am J Cardiol, 2005, 95 (9): 1025-1032.
7Natalie K, Wolfgang K. Predicting the risk of cardiovascular disease: where does lipoprotein-associated phospholipase A2 fit in? [ J ]. Molecular Diagnosis & Therapy, 2007,11(4) :203-217.
8Tjoelker LW, Wilder C, Eberhardt C, et al. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase [ J ]. Nature, 1995, 374(6522) :549-553.
9El-Saed A, Sekikawa A, Zaky RW, et al. Association of lipoprotein-associated phospholipase A2 with coronary calcification among American and Japanese men [ J ]. J Epidemiol, 2007,17(6) :179-185.
10Kolodgie FD, Burke AP, Skorija KS, et al. Lipoprotein associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis [ J ]. Arterioscler Thromb Vasc Biol, 2006, 26 (11) : 2523-2529.
同被引文献23
1Nambi Aiyar,Jyoti Disa,Zhaohui Ao,Haisong Ju,Sandhya Nerurkar,Robert N. Willette,Colin H. Macphee,Douglas G. Johns,Stephen A. Douglas.Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells[J]. Molecular and Cellular Biochemistry . 2007 (1-2)
2Jun-Lin Jiang,Xiao-Hong Zhang,Nian-Sheng Li,Wei-Qing Rang,Feng-Ye,Chang-Ping Hu,Yuan-Jian Li,Han-Wu Deng.Probucol Decreases Asymmetrical Dimethylarginine Level by Alternation of Protein Arginine Methyltransferase I and Dimethylarginine Dimethylaminohydrolase Activity[J]. Cardiovascular Drugs and Therapy . 2006 (4)
3Matsumoto T,Kobayashi T,KamataK.Role of lysophosphatidylcholine (LPC)in atherosclerosis. Current Medicinal Chemistry . 2007
4Camejo G.Lysophospholipids:effec-tors mediating the contribution ofdyslipidemia to calcification associat-ed with atherosclerosis. Atherosclerosis . 2010
5Leblanc N,Wan X,Leung PM.Physiological role of Ca (2+)-acti-vated and voltage-dependent K+currents in rabbit coronary myocytes. American Journal of Physiology Cell Physiology . 1994
6Bolick DT,Whetzel AM,SkaflenM,et al.Absence of the G protein-coupled receptor G2A in mice pro-motes monocyte/endothelial interac-tions in aorta. Circulation Research . 2007
7Parks BW,Lusis AJ,KabarowskiJH.Loss of the lysophosphatidylcho-line effector,G2A,ameliorates aor-tic atherosclerosis in low-density lip-oprotein receptor knockout mice. Arteriosclerosis and Thrombosis . 2006
8Stary HC,Chandler AB,Dinsmore RE,et al.A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation . 1995
9Inoue N,Takeshita S,Gao D,et al.Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells. Atherosclerosis . 2001
10Aiello EA,Clement Chomienne O,Sontag DP,Wslsh MP,Cole WC.Protein kinase C inhibits delayed rectifier K+ current in rabbit vascular smooth muscle cells. American Journal of Physiology . 1996
